Stockreport

LENZ Therapeutics: Speculative But Strong Buy [Seeking Alpha]

LENZ Therapeutics, Inc.  (LENZ) 
PDF I estimate a bit conservative base-case fair value of $25 per share, implying ~200% upside from current levels, driven by US and international partnerships. Key forwa [Read more]